Global Olaparib Market Growth 2022-2028
- LP 4768472
- 73 Pages
- January 2022
- Pharmaceuticals
The United States Olaparib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Olaparib market, reaching US$ million by the year 2028. As for the Europe Olaparib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Olaparib players cover AstraZeneca, Everest Pharmaceuticals, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Olaparib market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Tablets
Capsules
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Ovarian Cancers
Breast Cancers
Prostate Cancers
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AstraZeneca
Everest Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Olaparib Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Olaparib by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Olaparib by Country/Region, 2017, 2022 & 2028
2.2 Olaparib Segment by Type
2.2.1 Tablets
2.2.2 Capsules
2.3 Olaparib Sales by Type
2.3.1 Global Olaparib Sales Market Share by Type (2017-2022)
2.3.2 Global Olaparib Revenue and Market Share by Type (2017-2022)
2.3.3 Global Olaparib Sale Price by Type (2017-2022)
2.4 Olaparib Segment by Application
2.4.1 Ovarian Cancers
2.4.2 Breast Cancers
2.4.3 Prostate Cancers
2.4.4 Other
2.5 Olaparib Sales by Application
2.5.1 Global Olaparib Sale Market Share by Application (2017-2022)
2.5.2 Global Olaparib Revenue and Market Share by Application (2017-2022)
2.5.3 Global Olaparib Sale Price by Application (2017-2022)
3 Global Olaparib by Company
3.1 Global Olaparib Breakdown Data by Company
3.1.1 Global Olaparib Annual Sales by Company (2020-2022)
3.1.2 Global Olaparib Sales Market Share by Company (2020-2022)
3.2 Global Olaparib Annual Revenue by Company (2020-2022)
3.2.1 Global Olaparib Revenue by Company (2020-2022)
3.2.2 Global Olaparib Revenue Market Share by Company (2020-2022)
3.3 Global Olaparib Sale Price by Company
3.4 Key Manufacturers Olaparib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Olaparib Product Location Distribution
3.4.2 Players Olaparib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Olaparib by Geographic Region
4.1 World Historic Olaparib Market Size by Geographic Region (2017-2022)
4.1.1 Global Olaparib Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Olaparib Annual Revenue by Geographic Region
4.2 World Historic Olaparib Market Size by Country/Region (2017-2022)
4.2.1 Global Olaparib Annual Sales by Country/Region (2017-2022)
4.2.2 Global Olaparib Annual Revenue by Country/Region
4.3 Americas Olaparib Sales Growth
4.4 APAC Olaparib Sales Growth
4.5 Europe Olaparib Sales Growth
4.6 Middle East & Africa Olaparib Sales Growth
5 Americas
5.1 Americas Olaparib Sales by Country
5.1.1 Americas Olaparib Sales by Country (2017-2022)
5.1.2 Americas Olaparib Revenue by Country (2017-2022)
5.2 Americas Olaparib Sales by Type
5.3 Americas Olaparib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Olaparib Sales by Region
6.1.1 APAC Olaparib Sales by Region (2017-2022)
6.1.2 APAC Olaparib Revenue by Region (2017-2022)
6.2 APAC Olaparib Sales by Type
6.3 APAC Olaparib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Olaparib by Country
7.1.1 Europe Olaparib Sales by Country (2017-2022)
7.1.2 Europe Olaparib Revenue by Country (2017-2022)
7.2 Europe Olaparib Sales by Type
7.3 Europe Olaparib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Olaparib by Country
8.1.1 Middle East & Africa Olaparib Sales by Country (2017-2022)
8.1.2 Middle East & Africa Olaparib Revenue by Country (2017-2022)
8.2 Middle East & Africa Olaparib Sales by Type
8.3 Middle East & Africa Olaparib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Olaparib
10.3 Manufacturing Process Analysis of Olaparib
10.4 Industry Chain Structure of Olaparib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Olaparib Distributors
11.3 Olaparib Customer
12 World Forecast Review for Olaparib by Geographic Region
12.1 Global Olaparib Market Size Forecast by Region
12.1.1 Global Olaparib Forecast by Region (2023-2028)
12.1.2 Global Olaparib Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Olaparib Forecast by Type
12.7 Global Olaparib Forecast by Application
13 Key Players Analysis
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Olaparib Product Offered
13.1.3 AstraZeneca Olaparib Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
14 Research Findings and Conclusion
Table 1. Olaparib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Olaparib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of Capsules
Table 5. Global Olaparib Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Olaparib Sales Market Share by Type (2017-2022)
Table 7. Global Olaparib Revenue by Type (2017-2022) & ($ million)
Table 8. Global Olaparib Revenue Market Share by Type (2017-2022)
Table 9. Global Olaparib Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Olaparib Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Olaparib Sales Market Share by Application (2017-2022)
Table 12. Global Olaparib Revenue by Application (2017-2022)
Table 13. Global Olaparib Revenue Market Share by Application (2017-2022)
Table 14. Global Olaparib Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Olaparib Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Olaparib Sales Market Share by Company (2020-2022)
Table 17. Global Olaparib Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Olaparib Revenue Market Share by Company (2020-2022)
Table 19. Global Olaparib Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Olaparib Producing Area Distribution and Sales Area
Table 21. Players Olaparib Products Offered
Table 22. Olaparib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Olaparib Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Olaparib Sales Market Share Geographic Region (2017-2022)
Table 27. Global Olaparib Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Olaparib Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Olaparib Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Olaparib Sales Market Share by Country/Region (2017-2022)
Table 31. Global Olaparib Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Olaparib Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Olaparib Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Olaparib Sales Market Share by Country (2017-2022)
Table 35. Americas Olaparib Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Olaparib Revenue Market Share by Country (2017-2022)
Table 37. Americas Olaparib Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Olaparib Sales Market Share by Type (2017-2022)
Table 39. Americas Olaparib Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Olaparib Sales Market Share by Application (2017-2022)
Table 41. APAC Olaparib Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Olaparib Sales Market Share by Region (2017-2022)
Table 43. APAC Olaparib Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Olaparib Revenue Market Share by Region (2017-2022)
Table 45. APAC Olaparib Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Olaparib Sales Market Share by Type (2017-2022)
Table 47. APAC Olaparib Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Olaparib Sales Market Share by Application (2017-2022)
Table 49. Europe Olaparib Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Olaparib Sales Market Share by Country (2017-2022)
Table 51. Europe Olaparib Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Olaparib Revenue Market Share by Country (2017-2022)
Table 53. Europe Olaparib Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Olaparib Sales Market Share by Type (2017-2022)
Table 55. Europe Olaparib Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Olaparib Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Olaparib Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Olaparib Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Olaparib Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Olaparib Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Olaparib Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Olaparib Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Olaparib Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Olaparib Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Olaparib
Table 66. Key Market Challenges & Risks of Olaparib
Table 67. Key Industry Trends of Olaparib
Table 68. Olaparib Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Olaparib Distributors List
Table 71. Olaparib Customer List
Table 72. Global Olaparib Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Olaparib Sales Market Forecast by Region
Table 74. Global Olaparib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Olaparib Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Olaparib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Olaparib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Olaparib Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Olaparib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Olaparib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Olaparib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Olaparib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Olaparib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Olaparib Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Olaparib Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Olaparib Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Olaparib Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Olaparib Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Olaparib Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Olaparib Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Olaparib Revenue Market Share Forecast by Application (2023-2028)
Table 92. AstraZeneca Basic Information, Olaparib Manufacturing Base, Sales Area and Its Competitors
Table 93. AstraZeneca Olaparib Product Offered
Table 94. AstraZeneca Olaparib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. AstraZeneca Main Business
Table 96. AstraZeneca Latest Developments
Table 97. Everest Pharmaceuticals Basic Information, Olaparib Manufacturing Base, Sales Area and Its Competitors
Table 98. Everest Pharmaceuticals Olaparib Product Offered
Table 99. Everest Pharmaceuticals Olaparib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. Everest Pharmaceuticals Main Business
Table 101. Everest Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Olaparib
Figure 2. Olaparib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Olaparib Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Olaparib Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Olaparib Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of Capsules
Figure 11. Global Olaparib Sales Market Share by Type in 2021
Figure 12. Global Olaparib Revenue Market Share by Type (2017-2022)
Figure 13. Olaparib Consumed in Ovarian Cancers
Figure 14. Global Olaparib Market: Ovarian Cancers (2017-2022) & (K Pcs)
Figure 15. Olaparib Consumed in Breast Cancers
Figure 16. Global Olaparib Market: Breast Cancers (2017-2022) & (K Pcs)
Figure 17. Olaparib Consumed in Prostate Cancers
Figure 18. Global Olaparib Market: Prostate Cancers (2017-2022) & (K Pcs)
Figure 19. Olaparib Consumed in Other
Figure 20. Global Olaparib Market: Other (2017-2022) & (K Pcs)
Figure 21. Global Olaparib Sales Market Share by Application (2017-2022)
Figure 22. Global Olaparib Revenue Market Share by Application in 2021
Figure 23. Olaparib Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Olaparib Revenue Market Share by Company in 2021
Figure 25. Global Olaparib Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Olaparib Revenue Market Share by Geographic Region in 2021
Figure 27. Global Olaparib Sales Market Share by Region (2017-2022)
Figure 28. Global Olaparib Revenue Market Share by Country/Region in 2021
Figure 29. Americas Olaparib Sales 2017-2022 (K Pcs)
Figure 30. Americas Olaparib Revenue 2017-2022 ($ Millions)
Figure 31. APAC Olaparib Sales 2017-2022 (K Pcs)
Figure 32. APAC Olaparib Revenue 2017-2022 ($ Millions)
Figure 33. Europe Olaparib Sales 2017-2022 (K Pcs)
Figure 34. Europe Olaparib Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Olaparib Sales 2017-2022 (K Pcs)
Figure 36. Middle East & Africa Olaparib Revenue 2017-2022 ($ Millions)
Figure 37. Americas Olaparib Sales Market Share by Country in 2021
Figure 38. Americas Olaparib Revenue Market Share by Country in 2021
Figure 39. United States Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Olaparib Sales Market Share by Region in 2021
Figure 44. APAC Olaparib Revenue Market Share by Regions in 2021
Figure 45. China Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Olaparib Sales Market Share by Country in 2021
Figure 52. Europe Olaparib Revenue Market Share by Country in 2021
Figure 53. Germany Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Olaparib Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Olaparib Revenue Market Share by Country in 2021
Figure 60. Egypt Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Olaparib Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Olaparib in 2021
Figure 66. Manufacturing Process Analysis of Olaparib
Figure 67. Industry Chain Structure of Olaparib
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
